{"company": {"org_id": "T000251825", "org_name_cn": "成都欧林生物科技股份有限公司", "org_short_name_cn": "欧林生物", "org_name_en": "Chengdu Olymvax Biopharmaceuticals Inc.", "org_short_name_en": "Olymvax Biopharmaceuticals", "main_operation_business": "人用疫苗的研发、生产及销售。", "operating_scope": "　　预防用生物制品的生产（凭药品生产许可证在有效期内经营）；生物技术与生物制品的研究、开发、咨询并提供技术转让；生物制药市场的开发、咨询（不含危险化学品）；货物及技术进出口（国家禁止的品种除外，限制的品种办理许可方可经营）（依法须经批准的项目，经相关部门批准后方可开展经营活动）。", "district_encode": "510117", "org_cn_introduction": "成都欧林生物科技股份有限公司的主营业务是人用疫苗的研发、生产及销售。公司的主要产品是吸附破伤风疫苗、b型流感嗜血杆菌结合疫苗、A群C群脑膜炎球菌多糖结合疫苗。公司入选“中国品牌价值评价”，获得“中国产学研合作创新奖”“2023年度生产力促进(创新发展)二等奖”，并被评为“四川省技术创新示范企业”“2023年度四川省医药企业50强”。公司“严重致病菌疫苗关键技术创立及推广应用”获评“重庆市科技进步一等奖”。", "legal_representative": "樊绍文", "general_manager": "樊绍文", "secretary": "吴畏", "established_date": 1260460800000, "reg_asset": 405933600.0, "staff_num": 470, "telephone": "86-28-69361198", "postcode": "611731", "fax": "86-28-69361100", "email": "ir@olymvax.com", "org_website": "www.olymvax.com", "reg_address_cn": "四川省成都市郫都区高新区天欣路99号", "reg_address_en": null, "office_address_cn": "四川省成都市郫都区高新区天欣路99号", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1623081600000, "provincial_name": "四川省", "actual_controller": "樊绍文 (12.28%)，樊钒 (8.74%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "樊绍文", "executives_nums": 11, "actual_issue_vol": 40530000.0, "issue_price": 9.88, "actual_rc_net_amt": 358837300.00000006, "pe_after_issuing": 146.45, "online_success_rate_of_issue": 0.0308837, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}